Britt Gambino

Editor

All articles by Britt Gambino

pulmonary arterial hypertension types

News Briefs, PAH News Briefs

Sotatercept Reduces Pulmonary Vascular Resistance in PAH

March 31, 2021

Decrease in pulmonary vascular resistance at 24 weeks greater with sotatercept versus placebo for pulmonary arterial hypertension

Next post in News Briefs

NORD health equity

Virtual NORD Forum Advocates for Health Equity Among Rare Disease Patients